abstract |
The invention relates to 2,6-di-tert-butyl-4-methylphenol (BHT) alone or in combination with one or more other antioxidants and/or an anti-inflammatory for the prevention or treatment of COVID-19, an infection caused by the SARS-CoV-2 virus. |